 | • レポートコード：QAF27817 • 出版社/出版日：QYResearch / 2021年4月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の骨粗鬆症治療薬市場について種類別（吸収抑制薬、アナボリック薬）、用途別（女性、男性）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・骨粗鬆症治療薬市場の概要 ・世界の主要地域別骨粗鬆症治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の骨粗鬆症治療薬市場規模2016-2021：種類別（吸収抑制薬、アナボリック薬） ・世界の骨粗鬆症治療薬市場予測2012-2027：種類別（吸収抑制薬、アナボリック薬） ・世界の骨粗鬆症治療薬市場規模2016-2021：用途別（女性、男性） ・世界の骨粗鬆症治療薬市場予測2012-2027：用途別（女性、男性） ・骨粗鬆症治療薬のアメリカ市場規模と予測2016-2021 ・骨粗鬆症治療薬のヨーロッパ市場規模と予測2016-2021 ・骨粗鬆症治療薬の中国市場規模と予測2016-2021 ・骨粗鬆症治療薬の日本市場規模と予測2016-2021 ・骨粗鬆症治療薬の東南アジア市場規模と予測2016-2021 ・骨粗鬆症治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Eli Lilly、Novartis、Pfizer、Amgen、Merck、Novo nordisk、Actavis、Roche） ・骨粗鬆症治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・骨粗鬆症治療薬の市場動向・機会・課題 ・調査の結論 |
Osteoporosis is a disease where decreased bone strength increases the risk of a broken bone. It is the most common reason for a broken bone among the elderly. Bones that commonly break include the back bones, the bones of the forearm, and the hip. Until a broken bone occurs there are typically no symptoms. Bones may weaken to such a degree that a break may occur with minor stress or spontaneously. Chronic pain and a decreased ability to carry out normal activities may occur following a broken bone.
Osteoporosis Drugs is a kind of medicine for Osteoporosis, such as Fosamax, Actonel, Boniva, Zoledronic Acid (Reclast or Zometa) and others.
Osteoporosis, which literally means porous bone, is a disease in which the density and quality of bone are reduced. As bones become more porous and fragile, the risk of fracture is greatly increased. The loss of bone occurs silently and progressively. Often there are no symptoms until the first fracture occurs. Osteoporosis drugs are a kind of medicine for Osteoporosis. The types of osteoporosis drugs mainly include antiresorptive drugs and anabolic drugs.
The Brazil osteoporosis drugs is Very concentrated, the sales of top eight manufacturers account exceeds 70% of Brazil sales.
The antiresorptive drugs is the main types of osteoporosis drugs. In 2015, the sales revenue of antiresorptive drugs is about 109 M USD; its proportion of total osteoporosis drugs exceeds 73%.
Market Analysis and Insights: Global Osteoporosis Drugs Market
The global Osteoporosis Drugs market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Osteoporosis Drugs Scope and Market Size
The global Osteoporosis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Osteoporosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Antiresorptive Drugs
Anabolic Drugs
Segment by Application
Female
Male
The Osteoporosis Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Osteoporosis Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Eli Lilly
Novartis
Pfizer
Amgen
Merck
Novo nordisk
Actavis
Roche
1 Osteoporosis Drugs Market Overview
1.1 Osteoporosis Drugs Product Scope
1.2 Osteoporosis Drugs Segment by Type
1.2.1 Global Osteoporosis Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Antiresorptive Drugs
1.2.3 Anabolic Drugs
1.3 Osteoporosis Drugs Segment by Application
1.3.1 Global Osteoporosis Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Female
1.3.3 Male
1.4 Osteoporosis Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Osteoporosis Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Osteoporosis Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Osteoporosis Drugs Price Trends (2016-2027)
2 Osteoporosis Drugs Estimates and Forecasts by Region
2.1 Global Osteoporosis Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Osteoporosis Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Osteoporosis Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Osteoporosis Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Osteoporosis Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Osteoporosis Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Osteoporosis Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Osteoporosis Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Osteoporosis Drugs Estimates and Projections (2016-2027)
2.4.3 China Osteoporosis Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Osteoporosis Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Osteoporosis Drugs Estimates and Projections (2016-2027)
2.4.6 India Osteoporosis Drugs Estimates and Projections (2016-2027)
3 Global Osteoporosis Drugs Competition Landscape by Players
3.1 Global Top Osteoporosis Drugs Players by Sales (2016-2021)
3.2 Global Top Osteoporosis Drugs Players by Revenue (2016-2021)
3.3 Global Osteoporosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osteoporosis Drugs as of 2020)
3.4 Global Osteoporosis Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Osteoporosis Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Osteoporosis Drugs Market Size by Type
4.1 Global Osteoporosis Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Osteoporosis Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Osteoporosis Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Osteoporosis Drugs Price by Type (2016-2021)
4.2 Global Osteoporosis Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Osteoporosis Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Osteoporosis Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Osteoporosis Drugs Price Forecast by Type (2022-2027)
5 Global Osteoporosis Drugs Market Size by Application
5.1 Global Osteoporosis Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Osteoporosis Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Osteoporosis Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Osteoporosis Drugs Price by Application (2016-2021)
5.2 Global Osteoporosis Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Osteoporosis Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Osteoporosis Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Osteoporosis Drugs Price Forecast by Application (2022-2027)
6 North America Osteoporosis Drugs Market Facts & Figures
6.1 North America Osteoporosis Drugs Sales by Company
6.1.1 North America Osteoporosis Drugs Sales by Company (2016-2021)
6.1.2 North America Osteoporosis Drugs Revenue by Company (2016-2021)
6.2 North America Osteoporosis Drugs Sales Breakdown by Type
6.2.1 North America Osteoporosis Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Osteoporosis Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Osteoporosis Drugs Sales Breakdown by Application
6.3.1 North America Osteoporosis Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Osteoporosis Drugs Sales Breakdown by Application (2022-2027)
7 Europe Osteoporosis Drugs Market Facts & Figures
7.1 Europe Osteoporosis Drugs Sales by Company
7.1.1 Europe Osteoporosis Drugs Sales by Company (2016-2021)
7.1.2 Europe Osteoporosis Drugs Revenue by Company (2016-2021)
7.2 Europe Osteoporosis Drugs Sales Breakdown by Type
7.2.1 Europe Osteoporosis Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Osteoporosis Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Osteoporosis Drugs Sales Breakdown by Application
7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)
8 China Osteoporosis Drugs Market Facts & Figures
8.1 China Osteoporosis Drugs Sales by Company
8.1.1 China Osteoporosis Drugs Sales by Company (2016-2021)
8.1.2 China Osteoporosis Drugs Revenue by Company (2016-2021)
8.2 China Osteoporosis Drugs Sales Breakdown by Type
8.2.1 China Osteoporosis Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Osteoporosis Drugs Sales Breakdown by Type (2022-2027)
8.3 China Osteoporosis Drugs Sales Breakdown by Application
8.3.1 China 240 Sales Breakdown by Application (2016-2021)
8.3.2 China 240 Sales Breakdown by Application (2022-2027)
9 Japan Osteoporosis Drugs Market Facts & Figures
9.1 Japan Osteoporosis Drugs Sales by Company
9.1.1 Japan Osteoporosis Drugs Sales by Company (2016-2021)
9.1.2 Japan Osteoporosis Drugs Revenue by Company (2016-2021)
9.2 Japan Osteoporosis Drugs Sales Breakdown by Type
9.2.1 Japan Osteoporosis Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Osteoporosis Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Osteoporosis Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Osteoporosis Drugs Market Facts & Figures
10.1 Southeast Asia Osteoporosis Drugs Sales by Company
10.1.1 Southeast Asia Osteoporosis Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Osteoporosis Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Osteoporosis Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Osteoporosis Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Osteoporosis Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Osteoporosis Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Osteoporosis Drugs Market Facts & Figures
11.1 India Osteoporosis Drugs Sales by Company
11.1.1 India Osteoporosis Drugs Sales by Company (2016-2021)
11.1.2 India Osteoporosis Drugs Revenue by Company (2016-2021)
11.2 India Osteoporosis Drugs Sales Breakdown by Type
11.2.1 India Osteoporosis Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Osteoporosis Drugs Sales Breakdown by Type (2022-2027)
11.3 India Osteoporosis Drugs Sales Breakdown by Application
11.3.1 India Osteoporosis Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Osteoporosis Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Osteoporosis Drugs Business
12.1 Eli Lilly
12.1.1 Eli Lilly Corporation Information
12.1.2 Eli Lilly Business Overview
12.1.3 Eli Lilly Osteoporosis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Eli Lilly Osteoporosis Drugs Products Offered
12.1.5 Eli Lilly Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Osteoporosis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Osteoporosis Drugs Products Offered
12.2.5 Novartis Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Osteoporosis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Osteoporosis Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Amgen
12.4.1 Amgen Corporation Information
12.4.2 Amgen Business Overview
12.4.3 Amgen Osteoporosis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Amgen Osteoporosis Drugs Products Offered
12.4.5 Amgen Recent Development
12.5 Merck
12.5.1 Merck Corporation Information
12.5.2 Merck Business Overview
12.5.3 Merck Osteoporosis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Merck Osteoporosis Drugs Products Offered
12.5.5 Merck Recent Development
12.6 Novo nordisk
12.6.1 Novo nordisk Corporation Information
12.6.2 Novo nordisk Business Overview
12.6.3 Novo nordisk Osteoporosis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novo nordisk Osteoporosis Drugs Products Offered
12.6.5 Novo nordisk Recent Development
12.7 Actavis
12.7.1 Actavis Corporation Information
12.7.2 Actavis Business Overview
12.7.3 Actavis Osteoporosis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Actavis Osteoporosis Drugs Products Offered
12.7.5 Actavis Recent Development
12.8 Roche
12.8.1 Roche Corporation Information
12.8.2 Roche Business Overview
12.8.3 Roche Osteoporosis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Roche Osteoporosis Drugs Products Offered
12.8.5 Roche Recent Development
13 Osteoporosis Drugs Manufacturing Cost Analysis
13.1 Osteoporosis Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Osteoporosis Drugs
13.4 Osteoporosis Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Osteoporosis Drugs Distributors List
14.3 Osteoporosis Drugs Customers
15 Market Dynamics
15.1 Osteoporosis Drugs Market Trends
15.2 Osteoporosis Drugs Drivers
15.3 Osteoporosis Drugs Market Challenges
15.4 Osteoporosis Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Osteoporosis Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Osteoporosis Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Osteoporosis Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Osteoporosis Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Osteoporosis Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Osteoporosis Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Osteoporosis Drugs Revenue Share by Region (2016-2021)
Table 8. Global Osteoporosis Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Osteoporosis Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Osteoporosis Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Osteoporosis Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Osteoporosis Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Osteoporosis Drugs Sales Share by Company (2016-2021)
Table 14. Global Osteoporosis Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Osteoporosis Drugs Revenue Share by Company (2016-2021)
Table 16. Global Osteoporosis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Drugs as of 2020)
Table 17. Global Osteoporosis Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Osteoporosis Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Osteoporosis Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Osteoporosis Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Osteoporosis Drugs Sales Share by Type (2016-2021)
Table 23. Global Osteoporosis Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Osteoporosis Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Osteoporosis Drugs Sales Share by Type (2022-2027)
Table 26. Global Osteoporosis Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Osteoporosis Drugs Revenue Share by Type (2022-2027)
Table 28. Global Osteoporosis Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Osteoporosis Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Osteoporosis Drugs Sales Share by Application (2016-2021)
Table 31. Global Osteoporosis Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Osteoporosis Drugs Price (USD/Unit) by Application (2016-2021)
Table 33. Global Osteoporosis Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Osteoporosis Drugs Sales Share by Application (2022-2027)
Table 35. Global Osteoporosis Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Osteoporosis Drugs Revenue Share by Application (2022-2027)
Table 37. Global Osteoporosis Drugs Price (USD/Unit) by Application (2022-2027)
Table 38. North America Osteoporosis Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Osteoporosis Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Osteoporosis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Osteoporosis Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Osteoporosis Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Osteoporosis Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Osteoporosis Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Osteoporosis Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Osteoporosis Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Osteoporosis Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Osteoporosis Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Osteoporosis Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Osteoporosis Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Osteoporosis Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Osteoporosis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Osteoporosis Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Osteoporosis Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Osteoporosis Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Osteoporosis Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Osteoporosis Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Osteoporosis Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Osteoporosis Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Osteoporosis Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Osteoporosis Drugs Sales Market Share by Application (2022-2027)
Table 62. China Osteoporosis Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Osteoporosis Drugs Sales Market Share by Company (2016-2021)
Table 64. China Osteoporosis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Osteoporosis Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Osteoporosis Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Osteoporosis Drugs Sales Market Share by Type (2016-2021)
Table 68. China Osteoporosis Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Osteoporosis Drugs Sales Market Share by Type (2022-2027)
Table 70. China Osteoporosis Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Osteoporosis Drugs Sales Market Share by Application (2016-2021)
Table 72. China Osteoporosis Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Osteoporosis Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Osteoporosis Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Osteoporosis Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Osteoporosis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Osteoporosis Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Osteoporosis Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Osteoporosis Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Osteoporosis Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Osteoporosis Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Osteoporosis Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Osteoporosis Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Osteoporosis Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Osteoporosis Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Osteoporosis Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Osteoporosis Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Osteoporosis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Osteoporosis Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Osteoporosis Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Osteoporosis Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Osteoporosis Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Osteoporosis Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Osteoporosis Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Osteoporosis Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Osteoporosis Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Osteoporosis Drugs Sales Market Share by Application (2022-2027)
Table 98. India Osteoporosis Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Osteoporosis Drugs Sales Market Share by Company (2016-2021)
Table 100. India Osteoporosis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Osteoporosis Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Osteoporosis Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Osteoporosis Drugs Sales Market Share by Type (2016-2021)
Table 104. India Osteoporosis Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Osteoporosis Drugs Sales Market Share by Type (2022-2027)
Table 106. India Osteoporosis Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Osteoporosis Drugs Sales Market Share by Application (2016-2021)
Table 108. India Osteoporosis Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Osteoporosis Drugs Sales Market Share by Application (2022-2027)
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Eli Lilly Osteoporosis Drugs Product
Table 114. Eli Lilly Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Novartis Osteoporosis Drugs Product
Table 119. Novartis Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Pfizer Osteoporosis Drugs Product
Table 124. Pfizer Recent Development
Table 125. Amgen Corporation Information
Table 126. Amgen Description and Business Overview
Table 127. Amgen Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Amgen Osteoporosis Drugs Product
Table 129. Amgen Recent Development
Table 130. Merck Corporation Information
Table 131. Merck Description and Business Overview
Table 132. Merck Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Merck Osteoporosis Drugs Product
Table 134. Merck Recent Development
Table 135. Novo nordisk Corporation Information
Table 136. Novo nordisk Description and Business Overview
Table 137. Novo nordisk Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Novo nordisk Osteoporosis Drugs Product
Table 139. Novo nordisk Recent Development
Table 140. Actavis Corporation Information
Table 141. Actavis Description and Business Overview
Table 142. Actavis Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Actavis Osteoporosis Drugs Product
Table 144. Actavis Recent Development
Table 145. Roche Corporation Information
Table 146. Roche Osteoporosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Roche Description and Business Overview
Table 148. Roche Osteoporosis Drugs Product
Table 149. Roche Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Osteoporosis Drugs Distributors List
Table 153. Osteoporosis Drugs Customers List
Table 154. Osteoporosis Drugs Market Trends
Table 155. Osteoporosis Drugs Market Drivers
Table 156. Osteoporosis Drugs Market Challenges
Table 157. Osteoporosis Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Osteoporosis Drugs Product Picture
Figure 2. Global Osteoporosis Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Osteoporosis Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Female Examples
Figure 7. Male Examples
Figure 8. Global Osteoporosis Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Osteoporosis Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Osteoporosis Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Osteoporosis Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Osteoporosis Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Osteoporosis Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Osteoporosis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Osteoporosis Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Osteoporosis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Osteoporosis Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Osteoporosis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Osteoporosis Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Osteoporosis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Osteoporosis Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Osteoporosis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Osteoporosis Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Osteoporosis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Osteoporosis Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Osteoporosis Drugs Players Market Share by Revenue in Osteoporosis Drugs: 2016 & 2020
Figure 27. Osteoporosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Osteoporosis Drugs Revenue Share by Type (2016-2021)
Figure 29. Global Osteoporosis Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Osteoporosis Drugs Revenue Share by Application (2016-2021)
Figure 31. Global Osteoporosis Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Osteoporosis Drugs Sales Market Share by Type in 2020
Figure 33. North America Osteoporosis Drugs Sales Market Share by Application in 2020
Figure 34. Europe Osteoporosis Drugs Sales Market Share by Type in 2020
Figure 35. Europe Osteoporosis Drugs Sales Market Share by Application in 2020
Figure 36. China Osteoporosis Drugs Sales Market Share by Type in 2020
Figure 37. China Osteoporosis Drugs Sales Market Share by Application in 2020
Figure 38. Japan Osteoporosis Drugs Sales Market Share by Type in 2020
Figure 39. Japan Osteoporosis Drugs Sales Market Share by Application in 2020
Figure 40. Southeast Asia Osteoporosis Drugs Sales Market Share by Type in 2020
Figure 41. Southeast Asia Osteoporosis Drugs Sales Market Share by Application in 2020
Figure 42. India Osteoporosis Drugs Sales Market Share by Type in 2020
Figure 43. India Osteoporosis Drugs Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Osteoporosis Drugs
Figure 46. Manufacturing Process Analysis of Osteoporosis Drugs
Figure 47. Osteoporosis Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界の骨粗しょう症治療市場規模・現状・予測（2021年-2027年） Osteoporosis is a bone disease causing loss of bone density that occurs with age. It leads to million broken bones each year, and thus major reason of fractures, spinal problems, back pain, and loss of independence. Market Analysis and Insights: Global Osteoporosis Treatment Market The global Osteop…- 世界の女性用医薬品市場規模・現状・予測（2021年-2027年） Drugs specialized for women's health. Market Analysis and Insights: Global Women's Health Care Drugs Market The global Women's Health Care Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy i…
- 世界の女性用不妊治療薬市場規模・現状・予測（2021年-2027年） Female infertility refers to infertility in women. It affects an estimated 48 million women,with the highest prevalence of infertility affecting people in South Asia, Sub-Saharan Africa, North Africa/Middle East, and Central/Eastern Europe and Central Asia. The adverse effects and high cost of non-t…
- 世界の掻痒治療薬市場規模・現状・予測（2021年-2027年） Transdermal drug delivery systems are the most preferred methods of delivering pruritus drugs. The majority of the pruritus drugs are available in semi-solid topical dosage forms, such as lotions, gels, and creams, which are easier to apply, are less painful, and provides faster action than other fo…
- 世界の眼瞼炎薬市場規模・現状・予測（2021年-2027年） Blepharitis is one of the most common ocular conditions characterized by inflammation, scaling, reddening, and crusting of the eyelid. This condition may also cause burning, itching, or a grainy sensation when introducing foreign objects or substances to the eye. The development of novel drug formul…